While the initial cost of implementing point-of-care molecular diagnostic systems can be higher than traditional rapid antigen tests, the long-term economic benefits are undeniable. In a hospital setting, every hour saved in a diagnosis translates to lower operational costs and a higher turnover of beds. More importantly, the accuracy of molecular testing reduces the "hidden costs" of...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt